Skip to content
Medical Health Aged Care

Monash experts: World Health Day (7 April)

Monash University 2 mins read

Monash experts: World Health Day (7 April)

 

Sunday 7 April is World Health Day with this year’s theme, ‘My health, my right. Around the world, the right to health of millions is increasingly coming under threat.

 

This year’s theme was chosen to champion the right of everyone, everywhere to have access to quality health services, education, and information, as well as safe drinking water, clean air, good nutrition, quality housing, decent working and environmental conditions, and freedom from discrimination.

Available to comment:

 

Dr Ronli Sifris, Deputy Director, Castan Centre for Human Rights Law, Associate Professor, Monash Faculty of Law

Contact details: +61 488 360 033, ronli.sifris@monash.edu 

Read more of Dr Sifris’ commentary at Monash Lens

Read more about the framing of abortion as a human right in: Ronli Sifris, Towards Reproductive Justice (Monash University Publishing, 2024).

  • Abortion rights
  • Reproductive rights, access to IVF, surrogacy

 

The following can be attributed to Dr Sifris:

 

“International human rights law requires countries to refrain from negatively interfering with access to abortion, for example via laws that criminalise abortion. It also imposes a positive duty on governments to be proactive in ensuring the availability and accessibility of quality abortion services. For example, governments should make sure that abortion access is affordable. In Australia today there are a number of access issues, attributable for example to the cost of abortion and the ability of health facilities to refuse to provide abortion services.

 

“The international human rights system has recognised that a right to abortion falls within a number of established human rights norms, such as the: right to life, right to health, right to privacy, right to be free from discrimination, and right to be free from torture and other inhumane or degrading treatment. In the context of the right to health, the United Nations Committee on Economic, Social and Cultural Rights has  recognised that the right to sexual and reproductive health is an integral part of the broader right to health, and that the right to elective abortion is situated within the right to reproductive health.”

Professor Danielle Mazza AM, Professor and Head of General Practice, Monash University, and Director of the SPHERE NHMRC Centre of Research Excellence in Women's Sexual and Reproductive Health in Primary Care
Contact details: +61 423 208 747, danielle.mazza@monash.edu
Read more of Professor Mazza’s commentary at Monash Lens

  • Improving access to abortion and contraception
  • Primary care provision of women’s health services (GPs, nurses and pharmacists)
  • Preconception care. 

The following can be attributed to Professor Mazza:

“While essential women's health services such as abortion and IVF services continue to be restricted in the US, Australia has made some positive steps towards increasing access.

“Affordability of care is a critical issue, the other is supporting our workforce to deliver services particularly in rural and regional Australia and in priority populations."

Read more about issues around reproductive rights on Monash Lens.

 

For more Monash media stories visit our news & events site: monash.edu/news
For any other topics on which you may be seeking expert comment, contact the Monash University Media Unit on +61 3 9903 4840 or media@monash.edu

More from this category

  • Medical Health Aged Care
  • 31/10/2024
  • 17:55
Kyowa Kirin Co., Ltd.

Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company

Masashi Miyamoto to be named Chairman and CEO Abdul Mullick to be named President and COO Changes designed to further deliver on company’s 2030…

  • Contains:
  • Medical Health Aged Care
  • 31/10/2024
  • 12:10
MannKind

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

ICoN-1 study presentation planned November 1 at NTM Symposium AustraliaStudy is cleared by health authorities to proceed in Australia, U.S., Japan and South Korea, with Taiwan anticipated by end of year DANBURY, Conn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it has initiated its first site for its Phase 3 clinical trial evaluating efficacy and safety of Clofazimine Inhalation Suspension for the treatment of nontuberculous mycobacterial (NTM) lung disease. The study,…

  • Business Company News, Medical Health Aged Care
  • 31/10/2024
  • 11:03
Firebrick Pharma

Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore

Firebrick Pharmais pleased to announce that it has executed a Marketing Representation Agreement (the “Agreement”) with Singapore-based, Innorini, trading as Innorini Life Sciences (“Innorini”). The initial term of the Agreement is one year with the option to renew for subsequent one-year terms by mutual agreement. Under the Agreement, Innorini will undertake “Marketing Services” commencing 1 November 2024. The Marketing Services comprise sampling and promotion of Nasodine® Nasal Spray (“Nasodine”) to General Practitioners (“GPs”) and hospital-based doctors and pharmacists (collectively “HCPs”) in Singapore. In addition to building awareness and support of Nasodine by HCPs, Innorini will be expected to sell Nasodine…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.